Aortic Endograft Infections: A Race against Time

Abstract

Abdominal aortic aneurysms (AAAs) are a highly asymptomatic vascular pathology with an increasing risk of rupture, leading to high mortality. Upon detection, treatment primarily involves lifestyle changes to slow the growth rate. Aneurysm rupture requires immediate surgical intervention due to its high mortality. Endovascular aneurysm repair (EVAR) is a common treatment option, involving stent placement at the aneurysm site. However, the stent is a foreign body; therefore, it is susceptible to immune response and infection. This case series presents patients with infected endovascular stents following a diagnosis of abdominal infrarenal aortic aneurysm and EVAR. The patients’ follow-ups revealed varying prognoses, complications, and treatments post-infection. These findings are compared with outcomes reported in the medical literature. Preventing aortic stent graft infection through proper aseptic techniques is crucial. This practice reduces patient complications, shortens inpatient hospice stays, and, most importantly, enhances patient quality of life.